JBIO vs TRVI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

JBIO

48.9
AI Score
VS
TRVI Wins

TRVI

55.8
AI Score

Investment Advisor Scores

JBIO

49score
Recommendation
HOLD

TRVI

56score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric JBIO TRVI Winner
Net Income -96.13M -30.99M TRVI
Operating Income -102.36M -35.42M TRVI
ROE -21.9% -9.6% TRVI
ROA -20.4% -9.4% TRVI
Total Assets 472.11M 330.52M JBIO
Cash 107.25M 54.30M JBIO
Current Ratio 14.93 37.28 TRVI
Free Cash Flow -67.93M -34.34M TRVI

Relative Price Performance (Last 90 Days)

JBIO 1M: -22.9% · 3M: +11.3% TRVI 1M: -10.3% · 3M: +18.1%

Current Technical Phase

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 31

RSI (14): 31.1 · Price: $17.89

TRVI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 33

RSI (14): 33.4 · Price: $15.90

Fundamentals Snapshot

Metric JBIO TRVI
Market Cap
Forward P/E -6.7 -27.6
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin
Operating Margin 0.0% 0.0%
EPS -1.07 -0.33
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, TRVI is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.